Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Offer practical starter options for 2024, including how to evaluate coins, wallets, and purchasing steps for beginners.
23,507 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
A midlife couple faces a classic dilemma after selling a home: extinguish debt at 5% or invest the $175,000 cash pile...
Satellogic’s 2026 earnings hinge on a mix of recurring data licenses, expanding contracts, and efficient scaling. Thi...
As the first-quarter report for Innovate lands, investors eye more than just the top line. This guide breaks down wha...
A major fund trimmed its ACI Worldwide position, nudging the stock to trail the S&P 500 by a noticeable gap. This sto...
A widening disconnect between executive teams and frontline operations is dragging down loan-technology upgrades. The...
A once-niche software play may be quietly building a full AI-driven financial platform. This software stock could del...
Divisadero Street Capital Management upped its stake in Dave (DAVE), fueling questions about a potential buying oppor...
President Trump delayed signing an AI executive order after a late lobbying blitz by major tech figures. The move hig...
Driven Brands generated $1.9 billion in revenue, signaling a powerful multi-brand approach in the auto aftermarket. B...
A new tech challenger aims to blend space, AI, and hardware into one powerful growth engine. This article breaks down...
Energy stocks are rallying as market volatility persists, highlighting the best stocks right now for investors seekin...